Hohneker John has filed 8 insider transactions across 3 companies since January 2023.
Most recent transaction: a grant/award of 15502 shares of ArriVent BioPharma, Inc. ($AVBP) on June 18, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| June 18, 2025 | ArriVent BioPharma, Inc. | $AVBP | Hohneker John | Director | A | Non-Qualified Stock Option (right to buy) | 15502 | $0.00 | 15,502.0000 | 33,898,870 | 9999.99% | 0.05% |
| May 20, 2025 | CURIS INC | $CRIS | Hohneker John | Director | A | Non Qualified Stock Option | 14400 | $3.13 | 14,400.0000 | 6,306,284 | 9999.99% | 0.23% |
| Jan. 28, 2025 | CURIS INC | $CRIS | Hohneker John | Director | A | Non Qualified Stock Option | 1600 | $3.13 | 1,600.0000 | 6,306,284 | 9999.99% | 0.03% |
| June 26, 2024 | Carisma Therapeutics Inc. | $CARM | Hohneker John | Director | A | Stock Option (Right to Buy) | 19350 | $0.00 | 19,350.0000 | 0 | 9999.99% | 0.00% |
| May 21, 2024 | CURIS INC | $CRIS | Hohneker John | Director | A | Non Qualified Stock Option | 4250 | $11.62 | 4,250.0000 | 5,293,294 | 9999.99% | 0.08% |
| May 16, 2024 | ArriVent BioPharma, Inc. | $AVBP | Hohneker John | Director | A | Stock Option (right to buy) | 29550 | $0.00 | 29,550.0000 | 25,046,531 | 9999.99% | 0.12% |
| April 1, 2024 | Carisma Therapeutics Inc. | $CARM | Hohneker John | Director | A | Stock Option (Right to Buy) | 38700 | $0.00 | 38,700.0000 | 0 | 9999.99% | 0.00% |
| Jan. 23, 2023 | CURIS INC | $CRIS | Hohneker John | Director | A | Non Qualified Stock Option | 85000 | $0.00 | 85,000.0000 | 0 | 9999.99% | 0.00% |